The first national registry for prostate cancer (PCa) patients treated with stereotactic body radiation therapy has enrolled more than 500 men, according to an announcement made by the CyberKnife Coalition (CKC).
The Registry for Prostate Cancer Radiosurgery (RPCR), founded by the CKC in July 2010, tracks the clinical progress of men with localized PCa at academic and community centers in the United States. The trial, which is registered with the National Institutes of Health, will assist in determining the efficacy of radiosurgical treatment for early stage PCa patients. The RPCR also reports on quality of life information to the Centers for Medicare & Medicaid Services as well as local Medicare contractors.
The CKC is a non-profit organization whose members are encouraged to join the RPCR. Through participation, the CKC said it believes that their centers will be better equipped to suit the individual needs of patients.
Mark Perman, MD, a CKC board member and co-founder of the RPCR, said he hopes to have 20 centers participating by the end of the year. “I anticipate that the registry will become a mechanism for clinicians to measure the quality of the care they provide and will help fill in the evidence gaps pertaining to prostate radiation,” Dr. Perman said.